China Dasheng Biotechnology Company
CDBT · OTC
6/30/2023 | 6/30/2022 | 6/30/2008 | 10/31/2007 | |
|---|---|---|---|---|
| Market Cap | $3,032 | $2,400 | $58,500 | $19,605 |
| - Cash | $7 | $0 | $1,561 | $0 |
| + Debt | $1,029 | $0 | $0 | $0 |
| Enterprise Value | $4,054 | $2,400 | $56,939 | $19,605 |
| Revenue | $0 | – | $16,294 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | – | $7,504 | -$2 |
| % Margin | – | – | 46.1% | – |
| EBITDA | -$637 | – | $5,701 | -$8 |
| % Margin | – | – | 35% | – |
| Net Income | -$967 | – | $4,638 | -$68 |
| % Margin | – | – | 28.5% | – |
| EPS Diluted | -0.024 | – | 0.15 | -0.01 |
| % Growth | – | – | 1,600% | – |
| Operating Cash Flow | -$234 | – | $4,098 | – |
| Capital Expenditures | $0 | – | -$31 | – |
| Free Cash Flow | -$234 | – | $4,067 | – |